The European Medical Agency has already granted the status of orphan drugs to dexamethasone phosphate for the treatment of cystic fibrosis [247] and to l-asparaginase for the treatment of pancreatic cancer [248] and acute lymphoblastic leukemia [249]. This evidence concerns the gene ASPG and pancreatic neoplasm.